Close Menu

Quickly and cheaply is the goal of Pathogenica, a start-up that proposes to diagnose diseases using sequencing technology, reports MIT's Technology Review. By the end of 2012, the company hopes to have an FDA-approved product to detect the bacteria behind urinary tract infections, all for $10 a test. "The majority [of current tests] require days to get a result, which is frequently too late," says Columbia University's Ian Lipkin, who is on Pathogenica's board, to Tech Review.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.